Hypoxia-inducible factor 1 (HIF-1) is a crucial transcription factor for the cellular adaptive response to hypoxia, which contributes to multiple events in cancer biology. MicroRNAs (miRNAs) are involved in almost all cellular activities such as differentiation, proliferation, and apoptosis. In this work, we use miRNA microarrays to profile miRNA expression in acute myeloid leukemia (AML) cells with inducible HIF-1a expression, and identify 19 differentially expressed miRNAs. Our study shows that HIF-1a represses the expression of miR-17 and miR-20a by downregulating c-Myc expression. These two miRNAs alleviate hypoxia and HIF-1a-induced differentiation of AML cells. More intriguingly, miR-17 and miR-20a directly inhibit the p21 and STAT3 (signal transducer and activator of transcription 3) expression, both of which can reverse miR-17/miR-20a-mediated abrogation of HIF-1a-induced differentiation. Moreover, we show in vivo that miR-20a contributes to HIF-1a-induced differentiation of leukemic cells. Taken together, our results suggest that HIF-1a regulates the miRNA network to interfere with AML cell differentiation, representing a novel molecular mechanism for HIF-1-mediated anti-leukemic action.
Hypoxia-inducible factor-1 (HIF-1), a heterodimeric transcriptional factor that consists of the oxygen-sensitive alpha subunit (HIF-1a) and the constitutively expressed beta subunit (HIF-1b), is a master regulator for the cellular adaptive response to oxygen concentration. 1 Under normoxic conditions, proline residues 402 and 564 of the HIF-1a protein are hydroxylated by specific prolyl hydroxylases (PHDs) that utilize O 2 and a-ketoglutarate as co-factors. The hydroxylated HIF-1a protein is subject to ubiquitination by the E3 ubiquitin ligase von Hippel-Lindau (VHL), which leads to its degradation. In contrast, hypoxic conditions cause the accumulation of HIF-1a protein by inhibiting its hydroxylation, and subsequent ubiquitination and degradation. 2 The stabilized HIF-1a protein translocates into the nucleus, where it forms a heterodimer with HIF-1b and modulates the expression of hundreds of genes through binding to hypoxia-responsive elements (HREs; 5 0 -RCGTG-3 0 ) on their promoters. These HIF-1-targeted genes help the cell adapt to hypoxia by influencing processes such as erythropoiesis, angiogenesis, cell metabolism, growth, apoptosis, and differentiation.
Intriguingly, HIF-1a has been shown to contribute to the pathogenesis and progression of multiple kinds of diseases, including cancer. 1, 3 Although a hypoxic microenvironment is regarded as a hallmark of solid tumors, and hypoxia-stabilized HIF-1a protein contributes to tumor growth, angiogenesis, and metastasis, 4 several groups, including our own, have reported that HIF-1a protein can trigger acute myeloid leukemia (AML) cells to undergo differentiation through a transcription-independent mechanism, inhibiting the progression of AML. [5] [6] [7] [8] [9] MicroRNAs (miRNAs) are a distinct class of small noncoding RNAs of around 22 nucleotides in length that posttranscriptionally repress expression of target genes through imperfect base pairing with the 3 0 untranslated region (UTR), leading to the reduced translation and degradation of the mRNA. MiRNAs have been widely associated with the development of major diseases. 10 More recently, a functional link between HIF-1 and miRNA expression has been documented by some groups. HIF-1a can be targeted by the miR-17-92 cluster, miR-424 and miR-20b. [11] [12] [13] A specific group of miRNAs have been reported to be induced in response to hypoxia, at least partially via an HIF-1-dependent mechanism.
14 However, much less is known about possible effects of HIF-1 on the expression of miRNAs, and the role that this regulation may have in AML cells. Here, we provide the first demonstration that HIF-1a represses the expression of miR-17 and miR-20a in AML cells through downregulating c-Myc expression. We further show that these two miRNAs target p21 and STAT3 (signal transducer and activator of transcription 3). Our study shed light on a novel miRNAdependent mechanism through which HIF-1a induces differentiation and inhibits proliferation in leukemic cells.
Results
HIF-1a regulates the expression of a specific set of miRNAs in AML cells. To investigate how HIF-1a regulates the expression of miRNAs in AML cells, we compared miRNA expression profiles between U937T
HIF-1a and U937T empty cells that we established previously. 9 In U937T HIF-1a but not in U937T empty cells, HIF-1a protein is induced by tetracycline withdrawal (Figure 1a) . We grew both cell types in tetracycline-free medium for different periods of time and analyzed miRNA expression profiles using microarrays. The expression profiles of 19 miRNAs were significantly differentially expressed in the two cell types (Po0.05) (Figure 1b) . Out of these 19 miRNAs, 13 were upregulated in U937T
HIF-1a cells on days 2 and 4 in the tetracycline-free medium and 6 were downregulated (Figure 1b) . Intriguingly, four out of the six downregulated miRNAs belong to the miR-17-92 cluster. We validated the microarray data using real-time RT-PCR and northern blot analysis (Figures 1c and  d; Supplementary Figure S1 ).
HIF-1a downregulates miR-17 and miR-20a in AML cell lines. We used bioinformatics analysis to predict the most significant candidate miRNAs. Using miRNA-gene ontology (GO) network, we found that miR-17 and miR-20a were the strongest targets (Supplementary Figure S2, Excel 1) . Additionally, miR-17 and miR-20a showed the highest target gene degrees in miRNA-target gene network (Figure 2 ; Supplementary Excel 2). Thus, we focused on miR-17 and miR-20a in the following experiments. To confirm that HIF-1a downregulates miR-17 and miR-20a, we incubated U937 cells and another AML cell line, NB4 cells, under hypoxic conditions (1% O 2 ), which induced HIF-1a protein accumulation ( Supplementary Figures S3A and S4A ). More interestingly, hypoxia also decreased the expression of miR-17 and miR-20a in both AML cell lines (Supplementary Figures S3B, C S4B and C). Consistent with previous findings, 5,15 hypoxia also triggered growth arrest (Supplementary Figures  S3D and S4D ) and differentiation, as evidenced by the expression of CD11c, a mature myeloid cell surface marker (Supplementary Figures S3E and S4E) . Moreover, when HIF-1a was knocked down in the parental U937 cell line, hypoxia-induced miR-17 and miR-20a downregulation (Supplementary Figures S5A-C) was abrogated, suggesting that HIF-1a suppresses miR-17 and miR-20a expression during hypoxia.
HIF-1a inhibits miR-17 and miR-20a in a transcriptionindependent manner. To determine whether downregulation of miR-17 and miR-20a depends on the transcriptional activity of HIF-1 protein, we transfected shRNA against HIF-1a cells. Differential profiling using microarrays included three samples per group and time point. Red indicates upregulated and green shows downregulated miRNAs. The upper number of the map ' À 2 to 2' represents the z-value range, while the labels from S02-b to S18-17 represent sample names of different groups. (c and d) Validation of the downregulated expression of miR-17 or miR-20a by miRNA-specific qRT-PCR (c) and northern blot (d). Triplicate assays were done for each RNA sample and the relative amount of each miRNA was normalized to U6 snRNA. Statistically significant differences among three groups in different time point was indicated by *Po0.05
HIF-1b into U937T
HIF-1a cells (named as U937T
HIF-1a-shR-b5 cells) or a negative control shRNA (named as U937T
HIF-1a-NC cells). As depicted in Figure 3a , shR-b5 significantly silenced expression of HIF-1b. Accordingly, it also inhibited the expression of two commonly used HIF-1-targeted genes, vascular endothelial growth factor (VEGF) and Glut-1 in U937T HIF-1a-shR-b5 cells (Supplementary Figure S6) , confirming the effectiveness of HIF-1b knockdown. However, northern blot and RT-PCR assays showed that HIF-1b knockdown did not affect the downregulation of miR-17 or miR-20a by inducible expression of HIF-1a (Figures 3a and b) . In line with this notion, knockdown of HIF-1b also failed to affect hypoxia-induced downregulation of miR-17 and miR-20a (Supplementary Figures S7A-C) . These results suggest that the HIF-1-induced repression of miR-17 and miR-20a is independent of its transcriptional activity.
HIF-1a inhibits c-Myc expression via C/EBPa. Next, we detected the expression of c-Myc in U937T
HIF-1a cells, because it was reported that miR-17 or miR-20a could be positively regulated by c-Myc in several types of cells including diverse cancer cells. 16 Interestingly, HIF-1a protein accumulation after tetracycline withdrawal in U937T cells also decreased the expression of c-Myc (Figure 3c ). Furthermore, RT-PCR showed that c-Myc mRNA was decreased after tetracycline removal (Supplementary Figure S8A) , and the loss of c-Myc induced by HIF-1a overexpression could not be rescued by treatment with the proteasome inhibitor MG132 (Supplementary Figure S8B) or shRNA against HIF-1b (Supplementary Figures S8C and D) , indicating that HIF-1a decreases c-Myc through a proteasome and HIF-1b-independent mechanism. We previously reported that HIF-1a interacts with and increases the transcriptional activity of C/EBPa. 9,17 Thus, we assayed the effect of C/EBPa on c-Myc expression.
In the engineered U937T C/EBPa cells, C/EBPa protein was significantly induced after tetracycline withdrawal (Supplementary Figure S9A) , as described previously. 9 Upon the conditional induction of C/EBPa, c-Myc was significantly downregulated at both the mRNA and protein levels (Supplementary Figures S9A and B) . We stably introduced shRNA against C/EBPa expression (shR-C2) in U937T
HIF-1a cells. 9 As depicted in Supplementary Figure S9C , shR-C2 reduced C/EBPa protein with no influence on HIF-1a protein. HIF-1a cells (Figure 3d ), which was also confirmed with a miR-17 or miR-20a promoter-driven luciferase assay (Figure 3e) . These results suggest a role of reduced c-Myc expression in the HIF-1a-mediated downregulation of miR-17 and miR-20a.
MiR-17 and miR-20a inhibit HIF-1a-triggered differentiation of AML cell lines. Previously, we reported that HIF-1a-induced differentiation of AML cells is independent of its transcriptional activity. 9 These results parallel HIF-1a regulation of miR-17 and miR-20a described here. Thus, we considered whether the downregulation of miR-17 and miR-20a is related to hypoxia/HIF-1a-induced differentiation in leukemic cells. For this purpose, we infected U937T differentiation, we performed functional analysis of miRNAs using the Kyoto Encyclopedia of Genes and Genomes (KEGG). The results revealed that 48 signal transduction pathways were regulated (Supplementary Excel 3). This includes some pathways that were previously reported as closely related to cell differentiation including the AML activated cell cycle, and the Jak-STAT signaling pathways (Supplementary Figure S11) . [18] [19] [20] Meanwhile, among all computationally predicted target genes of miR-17 and miR-20a, p21 and STAT3 stood out as having been reported to be involved in the cell cycle and the Jak-STAT signaling pathways. 21, 22 Moreover, these two target genes were only regulated by miR-17, miR-20a, and miR-106a ( Figure 2) . Therefore, the relation of miR-17 and miR-20a to p21 and STAT3 might be of great importance to HIF-1a-induced AML cell differentiation. Indeed, p21 and STAT3 proteins were progressively upregulated on days 2 and 4 after tetracycline removal in U937T
HIF-1a but not in U937T empty cells (Figure 5a ), which paralleled the decreased expression of miR-17 and miR-20a. More intriguingly, ectopic expression of miR-17 and miR-20a reduced the protein levels of p21 and STAT3 on days 2 and 4 after tetracycline removal in U937T HIF-1a cells (Figure 5b ), suggesting that p21 and STAT3 may be direct targets of miR-17 and miR-20a. To validate this, we performed a 3 0 UTR luciferase reporter assay. A miRNA:mRNA alignment analysis clearly showed that the wild-type 3 0 UTR of p21 and STAT3 contains two miR-17/ miR-20a binding sites (Figure 5c ). Thus, they were cloned immediately upstream of the firefly luciferase gene in the pMIR-REPORT vector. The relative luciferase activity of the HIF-1a transformants (%), (e) cell morphology of the three U937T HIF-1a transformants, and (f) NBT reduction of the six transformants (6 days after tetracycline removal). The symbols * and # represented Po0.05 compared respectively with U937T
HIF-1a-p-Mig cells
Regulation of miR-17/20a by HIF-1a in leukemia M He et al construct with wild-type 3 0 UTR of p21 or STAT3 was significantly repressed following the transfection of miR-17 or miR-20a (Figure 5d) . Furthermore, the repression of relative luciferase activity was clearly abrogated when single (M2) and especially double (M1 þ M2) conserved sites were mutated in the 3 0 UTR of p21 or STAT3 (Figure 5d ). All these data support the conclusion that miR-17 or miR-20a may suppress both p21 and STAT3 protein expression through directly targeting their 3 0 UTR at the post-transcriptional level.
MiR-17 and miR-20a counteract the effects of HIF-1a by inhibiting p21 and STAT3. To determine whether miR-17/20a acts through p21 and STAT3 to inhibit the effects of HIF-1a on AML cell lines, we first knocked down the expression of p21 and STAT3. U937T empty and U937T
HIF-1a cells were stably transfected by shRNAs against p21 (shRp21-1, shR-p21-2), STAT3 (shR-ST-1, shR-ST-2) or luciferase as a control (shR-Luc). With the knockdown of p21 or STAT3 (Supplementary Figures S12A and B) , the growth arrest induced by HIF-1a was partially abrogated (Supplementary Figures S12C and D) . Meanwhile, the differentiation of these cells induced by HIF-1a was also suppressed (Supplementary Figures S12E and F) . Next, we investigated whether overexpression of p21 or STAT3a in the miR-17 or miR-20a overexpressed U937T HIF-1a cells could inhibit the effects of the miRNAs. We infected and U937T
HIF-1a-miR-20a cells (grouped as miR17-p21 and miR-20a-p21, respectively) abrogated the cell proliferation induced by miR-17 and miR-20a overexpression (grouped as miR17-DsRed and miR-20a-DsRed) (Figure 6a) .
Overexpression of p21 in the U937T HIF-1a-miR-17 and U937T
HIF-1a-miR-20a cells also reversed the effects of miR-17 and miR-20 on cell-cycle arrest (Figure 6b ) and differentiation (Figure 6c) . Overexpression of STAT3a led to the same effects as p21 (Figures 6d-g ). Taken together, these results suggest that miR-17 or miR-20a inhibits HIF-1a-induced growth arrest and differentiation by inhibiting p21 and STAT3 expression.
MiR-20a inhibits U937 cell differentiation induced by HIF-1a and promotes U937 cell proliferation in vivo. To further evaluate the role of miR-20a in vivo, we used a xenograft model of increasing immune deficiency: NOD/ SCID mice treated with anti-CD122 antibody to deplete innate immune cells. The anti-CD122 antibody directs against the IL-2Rb chain and targets several mature HIF-1a cells from 0.9 to 3.5%, when equal numbers of cells were transplanted (Figure 7b ). Most importantly, consistent with our in vitro results, we found that HIF-1a increased the expression of CD11c in isolated human U937 cells 10 days after transplantation, while miR-20a attenuated this increase (68.52±1.46 versus 47.84±2.15%) (Figure 7c ). Furthermore, the morphology of U937 cells isolated from bone marrow validated the observation that U937 cell differentiation induced by HIF-1a was partially inhibited by miR-20a (Figure 7d ). It is worthwhile to mention that the rescue by miR-20a expression is modest compared with what was observed in vitro. This is possibly due to the longer time course compared with the in vitro experiments (the in vivo experiments were conducted 21 days (for proliferation) and 10 days (for differentiation) after transplantation, respectively, while the in vitro experiments were conducted 6 days after tetracycline withdrawal). Moreover, other HIF-1a-regulated factors such as gelactin-1 15 and the bone marrow environment could also have some influence on the transplanted human cells. Collectively, our data indicate that miR-20a inhibits the cellular differentiation and reduced proliferation induced by HIF-1a in leukemic cells in vivo.
Discussion
In this study, we comprehensively analyzed how HIF-1a affected miRNA expression by generating HIF-1a inducible AML cells. Through this, we provided the first demonstration that HIF-1a downregulates the expression of miR-17 and miR20a. Recently, a series of studies reported that the expression of the miR-17-92 cluster can be regulated by various transcription factors, including c-Myc, E2F, AML1, cyclin D1, and p53 in diverse cell types. 16, [25] [26] [27] [28] As a transcription factor, the transcriptional activity of HIF-1a requires its heterodimerization with HIF-1b. However, when HIF-1b expression was silenced by its specific shRNA, inducible expression of HIF-1a still repressed miR-17 and miR-20a. Hence, we extrapolated that HIF-1a protein regulates miR-17 and miR-20a expression through a transcription-independent manner. Of great interest, HIF-1a induction also inhibited the expression of c-Myc, and we showed that this was due to C/EBPa. Furthermore, we proved that reduced c-Myc expression contributes to HIF-1a-induced repression of miR-17 and miR-20a expression. It is noteworthy that a previous study reported that the expression levels of the miR-17-92 cluster were reduced in hypoxic cells containing wild-type p53 but not p53-deficient cells, and the repression of the miR-17-92 cluster under hypoxia was independent of c-Myc in colon cancer cell lines. 27 However, U937T cells do not express p53 (Supplementary Figure S14) and HIF-1a still represses miR-17 and miR-20a expression. The contradiction with the previous report may be due to the different cellular contexts of leukemia and solid tumors. MiR-17 and miR-20a belong to a highly conserved gene cluster-miR-17-92, a miRNA polycistron also known as oncomir-1, and may have parallel roles through regulating the same target genes because they contain the same seed sequence. The expression levels of miR-17 and miR-20a have great importance since miR-17 inhibition affects cancer cell growth only in cells that have high expression of the miR-17-92 cluster, whereas other cell types with lower expression of miR-17-92 remain unaffected. 29 Previous expression profiling studies have shown that miR-17 and miR-20a are overexpressed in a wide variety of solid tumors and hematopoietic malignancies, such as diffuse large B-cell lymphomas (DLBCLs), mantle cell lymphomas, and Burkitt's lymphomas. [30] [31] [32] Our current study also shows that the expression of miR-17 or miR-20a is significantly higher in U937 cells compared with cord blood mononuclear cells (CBMC) (Supplementary Figure S15) .
In addition, the precise roles of the miR-17-92 cluster in hematopoietic development and hematopoietic malignancies remain controversial according to different reports. In the absence of miR-17-92, hematopoietic development proceeds normally, except for an isolated defect in B-cell development. 33 However, in the in vitro differentiation system of human CD34
þ hematopoietic progenitor cells, miR-17, miR-20a, and miR-106a control monocytopoiesis. 25 Because previous investigations proposed that HIF-1a can trigger AML cells to undergo differentiation through a transcriptionindependent mechanism, we tried to explore the potential role of the reduced miR-17 and miR-20a expression in HIF-1a-induced AML cell differentiation. Our study strongly suggests that the downregulation of miR-17 and miR-20a plays a role in AML cell differentiation induced by HIF-1a or hypoxia in vitro and in vivo, because their ectopic expression effectively antagonized hypoxia or HIF-1a induction-triggered NB4 or U937 cell differentiation. Consistent with the effects of overexpressing miR-17 and miR-20a, c-Myc overexpression also partly attenuated HIF-1a-induced cell-cycle arrest and differentiation (Supplementary Figure S16) .
KEGG and miRNA-target gene network analysis suggests that p21 and STAT3 are among the strongest computationally predicted targets of miR-17 and miR-20a, and both genes are likely to participate in the cell cycle and the Jak-STAT signaling pathways. p21 is an inhibitor of cell-cycle progression, exerting its effect through interaction with cyclindependent kinase (CDK) complexes and arresting cells in G0/1 phase. 21 Moreover, p21 is closely correlated with the induction of differentiation in U937 cells, which can occur independently of p53. 18 STAT3 activation in myeloid cell lines promotes differentiation of neutrophils and macrophages, although overexpression of STAT3 partially impairs macrophage differentiation of M1 cells. 34 p21 has previously been reported to be a target of miR-17 and miR-20a in MLL leukemia stem cells and gastric epithelial cells, and more recently in iPS cells. [35] [36] [37] STAT3 has also been found to be a target of miR-17 and miR-20a in mouse ES cells and mouse myeloid-derived suppressor cells. 38, 39 Here, we show that miR-17 and miR-20a can target the p21 and STAT3 3 0 UTR to inhibit the expression of p21 and STAT3 in human cells. STAT3 exists in two isoforms, STAT3a and STAT3b, and they share a similar 3 0 UTR sequences. Consequently, miR-17 and miR-20a can directly repress both isoforms, which are consistent with our data. The ratio of STAT3a/STAT3b protein is reported to decrease with myeloid cell maturation and activation. 40 However, the difference of the ratio of STAT3a/ STAT3b is not statistically significant in our report, which suggests that miR-17 and miR-20a repress both isoforms equally. Furthermore, STAT3a itself may promote myeloid cell differentiation and this was the reason why we only overexpress STAT3a in the knockdown and rescue experiments.
In summary, we demonstrated that HIF-1a downregulates the expressions of miR-17 and miR-20a through a mechanism that is dependent of c-Myc but independent of its transcription partner HIF-1b. Furthermore, we uncovered the important role of miR-17 and miR-20a in HIF-1a-induced myeloid differentiation and growth arrest in AML cells in vitro and in vivo and verified that p21 and STAT3 are their functional target genes. These discoveries should shed new insights for using miRNAs as the novel therapeutics for the treatment of AML.
Materials and Methods
Cell lines, cell cycle, and differentiation assay. To provide direct evidence for the role of HIF-1a in AML cell differentiation and its mechanisms, we generated myeloid leukemic U937T transformants (U937T HIF-1a cells), in which HIF-1a was tightly induced by tetracycline withdrawal. U937T empty and U937T
HIF-1a cells were cultured in RPMI-1640 medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT, USA), 1 mg/ml of tetracycline and 0.5 mg/ml of puromycin (Sigma-Aldrich).
9 U937T stable transformants with inducible C/EBPa and empty vector (U937T C/EBPa and U937T PTRE ) were established as described previously. 15 All cell lines were cultured in 5% CO 2 /95% air in a humidified atmosphere at 371C. For hypoxic treatment, the NB4 and U937 transformants were cultured in a specially designed hypoxia incubator (Thermo Electron, Forma, MA, USA) in an atmosphere that consists of 94% N 2 , 5% CO 2 , and 1% O 2 . In all experiments, cell viability exceeded 95%, as determined by a trypan-blue exclusion assay. For morphological characterization, cells were collected onto slides by cytospinning (Shandon, Runcorn, UK), stained with Wright's stain and examined by light microscopy (Olympus, BX-51, Tokyo, Japan). The differentiation antigens were measured using phycoerythrin (PE)-or allophycocyanin (APC)-labeled anti-CD11c, CD11b, or CD14, with isotype controls (BD Biosciences, San Jose, CA, USA), via flow cytometry (Beckman-Coulter, Miami, FL, USA). The NBT reduction test was performed as previously described. 15 The distribution of nuclear DNA contents was analyzed by flow cytometry (Beckman-Coulter).
MiRNA microarray analysis. Microarray analysis was performed on 5 mg of total RNA from 18 samples including 3 separate samples of U937T empty or U937T HIF-1a cells at 0, 2, and 4 days after tetracycline removal, which were size fractionated using a YM-100 Microcon centrifugal filter (Millipore, Billerica, MA, USA) and the small RNAs (o300 nt) isolated were 3 0 -extended with a poly(A) tail using poly(A) polymerase. An oligo nucleotide tag was then ligated to the poly(A) tail for later fluorescent dye staining. Hybridization was performed overnight on a mParaflo microfluidic chip using a micro-circulation pump (Atactic Technologies, Houston, TX, USA). On the microfluidic chip, each detection probe consisted of a chemically modified nucleotide coding segment complementary to target miRNAs (from miRBase; http://microrna.sanger.ac.uk/sequences/) and a spacer segment of polyethylene glycol to extend the coding segment away from the substrate. The detection probes were made by in situ synthesis using PGR (photogenerated reagent) chemistry. The hybridization melting temperatures were balanced by chemical modifications of the detection probes. Hybridization was done using 100 ml 6 Â SSPE buffer (0.90 M NaCl, 60 mM Na 2 HPO 4 , 6 mM EDTA, pH 6.8) containing 25% formamide at 341C. After hybridization, detection was performed using fluorescence labeling with tag-specific Cy5 dyes. Hybridization images were collected using a laser scanner (GenePix 4000B, Molecular Device, Sunnyvale, CA, USA) and digitized using Array-Pro image analysis software (Media Cybernetics, Silver Spring, MD, USA). Data were analyzed by first subtracting the background and then normalizing the signals using a LOWESS filter (Locally weighted Regression).
The ratio of the three or six sets of detected signals (log 2 (2d or 4d/0d)) and P-values of the one-way ANOVA test were calculated; differentially detected signals were those with a P-value of o0.05. Regulated miRNAs were divided into high or low signal using a signal intensity value of 500 normalized signal units.
GO terms and KEGG pathway annotation based on miRNA expression profile. We pooled the reported and predicted targets of filtered miRNAs from the TargetScanHuman database (http://www.targetscan.org/). Bioinformatics analyses were performed using Matlab to identify the significant functions and significant pathways of the miRNA target genes. The top 25% miRNA targets that had been assigned the highest numbers of miRNA interaction sites were collected, and subjected to GO term analysis. GO analysis was applied in order to organize genes into hierarchical categories and uncover the miRNAgene regulatory network on the basis of biological process and molecular function. To identify significant functions, GO enrichment analysis was performed according to the GO database with a P-value of o0.01 as calculated by Fisher's exact test and the w 2 test and corrected by a false discovery rate (FDR and an FDR of o0.01). In addition, enrichment was regarded as a measure of the significance in gene function to find those GOs with a more concrete function description in the differential miRNA. Similarly, significant pathways were identified based on the KEGG (http://www.genome.jp/kegg/).
MiRNA-GO network. MiRNA-GO network is built according to the relationship of miRNAs and significant GOs. In the miRNA-GO network, the circle represents GO and the shape of red square represents miRNAs, and their relationship was represented by one edge. The center of the network was represented by degree. Degree of miRNA means how many links one miRNA regulates GOs. The core miRNAs in the network always have the highest degrees.
MiRNA-target gene network. Differentially miRNA target genes in significant GO and pathway categories, obtained from GO and pathway analyses, were analyzed by miRNA-target gene network. The relationship of the miRNAs and target genes was counted by their differential expression values, and according to the interactions of miRNA and target genes in Sanger miRNA database to build the miRNA-target gene network. In the miRNA-target gene network, the circle represents target gene and the shape of square represents miRNA, and their relationship is represented by one edge. The center of the network was represents by degree. Degree of miRNA means how many links one miRNA regulates target genes. The core miRNAs in the network always have the highest degrees.
Real-time RT-PCR. Total RNA extracted from cells was used to generate cDNA using ImProm-II TM Reverse Transcription System (Promega, Madison, WI, USA) with specific stem-loop primers for miRNA and random primer for mRNA. Real-time quantitative PCR was performed using SYBR Green PCR Master Mix (Applied Biosystems, Warrington, UK) in an Applied Biosystems 7300 instrument. The relative RNA amount was calculated with the DDCt method and normalized with internal control U6 snRNA (for mature miRNAs) and b-actin mRNA (for mRNAs). All reactions were run in triplicate. Primer sequences are detailed in Supplementary Table S1 .
Western blot. Cell lysates were fractionated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and then transferred onto nitrocellulose membrane (Axygen, Union City, CA, USA). After blocking with 5% non-fat milk in Tris-buffered saline, the membranes were incubated with the antibodies against HIF-1a, HIF-1b (BD Transduction, San Jose, CA, USA), c-Myc, p53 (Santa Cruz, CA, USA), STAT3, p21, and C/EBPa (Cell Signaling, Beverly, MA, USA) followed by horseradish peroxidase (HRP)-linked secondary antibodies (Cell Signaling) for 1 h at room temperature. Detection was performed by chemiluminescence phototope-HRP kit according to manufacturer's instruction (Cell Signaling). As necessary, blots were stripped and reprobed with anti-b-actin (Merck, Darmstadt, Germany) antibody as internal controls. All experiments were repeated three times.
DNA constructs. To stably express miR-17 or miR-20a or c-Myc in U937T empty or U937T HIF-1a cells and NB4 cells, miR-17 and miR-20a expression cassette containing the human miR-17 and miR-20a hairpin sequence and flanking regions were cloned from human genomic DNA isolated from U937 cells using the primer set in Supplementary Table S1 UTR of p21 or STAT3, which contains miR-17 and miR-20a-binding sites, was cloned immediately downstream of the firefly luciferase gene in the pMIR-REPORT vector after amplification of genomic DNA from human U937 cells using the primer sets in Supplementary Table S1 (3 0 UTR WT). The mutated 3 0 UTRs of respective mRNAs were amplified with the specific primers in which 3 bp in the 3 0 UTR of p21 or STAT3 genes corresponding to the position of 2, 4, and 6 oriented from the 5 0 terminus of mature miR-17 or miR-20a was mutated (3 0 UTR mutant M2 or M1 þ 2). The mutation included only mutation of second conserved sites (3 0 UTR mutant M2) and jointly (3 0 UTR mutant M1 þ M2). For shRNA experiments, pairs of complementary oligonucleotides against HIF-1a (shR-a14 and shR-a16), HIF-1b (shR-b2 and shR-b5), p21 (shR-p21-1 and shR-p21-2), STAT3a (shR-ST-1 and shR-ST-2) and C/EBPa (shR-C2) were synthesized by Invitrogen (Shanghai, China), annealed and ligated into pSilencer 3.1-H1-neo vector (Ambion, Austin, TX, USA). Target sequences are provided in Supplementary Table S1 .
Luciferase assays. HEK293T cells were seeded in 24-well plates at a density of 2.0 Â 10 5 cells per well and allowed to grow for 24 h before transfection. Then, each well was transiently co-transfected with 100 ng reporter plasmids of either wild-type or mutant 3 0 UTR of STAT3 or p21 construct pMIR-REPORT (Ambion), 60 pmol NC or miR-17, miR-20a mimics and 10 ng internal control vectorpRL-SV40 (Promega) using lipofectamine 2000. Cell lysates were harvested 36 h post transfection and then firefly and renilla luciferase activities were measured by the Dual-Luciferase Reporter Assay System (Promega) on a Berthold AutoLumat LB9507 rack luminometer (Rockford, IL, USA). The value of relative luciferase activity denotes the firefly luciferase activity normalized to that of renilla for each assay. To test if c-Myc can regulate miR-17-92 expression, we constructed the promoter of miR-17-92 using pGL4.10 vector (pGL4 prom17) that carried the promoter luciferase assay as previously reported. 25 Northern blot. Total RNA isolation was performed using the acid phenolguanidinium thiocyanate-chloroform protocol. RNA samples (20 mg each) were run on 15% acrylamide urea-denaturing precast gel (Invitrogen, Carlsbad, CA, USA), and transferred onto Hybond-N þ membrane (Amersham Biosciences, Little Chalfont, UK). The hybridization was performed overnight with miRCURY LNA miRNA Detection Probes labeled with Digoxin (Exiqon, Vedbaek, Denmark), at 421C in hybridization buffer (7% SDS, 0.2 M Na 2 HPO 4 ). Human U6 snRNA was used as a loading control. Probe detection was performed using the DIG Luminescent Detection Kit (Roche, Penzberg, Germany) according to manufacturer's protocol. The optical densities of RNA bands were quantified using Quantity One Software (Bio-Rad, Hercules, CA, USA). The ratio of the densities of miR-17 or miR-20a to that of U6 snRNA represents the relative expression level of each miRNA.
Transplantation of U937T cells in mice. All animal experiments were performed with the approval of the committee for humane treatment of animals at Shanghai Jiao Tong University School of Medicine. The animals were handled under sterile conditions. NOD/SCID repopulation assay by intravenous injection was performed as previously described. 24 Six-to eight-week-old female NOD/ SCID mice received 350 cGy of total body irradiation, 24 h before transplantation. Mice were given injections of 200 mg purified anti-CD122 antibody into the intraperitoneal cavity immediately following irradiation. The anti-CD122 monoclonal antibody was generated from the hybridoma cell line, TM-b1 (from Dr. T Tanaka of Hyogo University of Health Sciences, Kobe, Japan). The purified U937T empty-p-Mig , U937T
HIF-1a-p-Mig , and U937T HIF-1a-miR-20a cells (GFP positive) were washed twice and then intravenously injected (1 Â 10 7 cells suspended in 200 ml phosphatebuffered saline (PBS) without tetracycline per mouse, n ¼ 10 for each group), PBS as control group. One week before irradiation, the recipient mice were given acidified, antibiotic water. Neither water nor food contained tetracycline. Mice were monitored and killed at 10 days (n ¼ 5) and 21 days (n ¼ 3) after the injection for bone-marrow cells harvest.
